Bleeding at Seven Weeks With an Empty Uterus

This is a pregnancy of unknown location (PUL).

The key number is the discriminatory zone: an intrauterine gestational sac should be visible on transvaginal ultrasound somewhere around an hCG of 3,500 mIU/mL. At 1,420 mIU/mL, an empty uterus is entirely compatible with a normal early intrauterine pregnancy that is simply too small to see. It is also compatible with an early miscarriage and - critically - with an ectopic pregnancy.

What the ultrasound does and does not tell you: the absence of an adnexal mass and of free fluid makes a large, ruptured ectopic unlikely, but it does not exclude ectopic pregnancy. Small ectopics are routinely invisible.

Plan:

• Repeat quantitative hCG in 48 hours. The trend is the diagnostic tool at this stage, not a single value.
• Give anti-D immune globulin - she is Rh-negative with bleeding.
• Return precautions in writing: severe or one-sided pain, syncope, shoulder tip pain, heavy bleeding, dizziness - go to the emergency department immediately.
• Pelvic rest and avoid NSAIDs, which can mask pain and affect interpretation.
• Safety-netting by phone: a scheduled follow-up contact, not a vague "call if worse."

Reassurance without a plan would be the error here. She may well have a normal pregnancy, but you cannot say that yet.

This is a shared decision with a concrete safety plan, not a permission question.

What I say:

• The chance of a catastrophic rupture at this hCG with no free fluid is low, but it is not zero, and the risk window is the next several days - precisely when she would be away.
• If she travels, the workup travels with her: I will help arrange a repeat quantitative hCG and ultrasound at her destination, or she can return early.
• She needs written warning signs and a plan for what to do if pain or bleeding starts at 30,000 feet - land and go to an emergency department.
• I give her my contact information and the results of the testing so far.

Documentation:

• The diagnosis of PUL, the differential, and why expectant reassurance alone is unsafe.
• The specific counseling given about rupture and the warning signs, in her own words where possible.
• Her decision to travel, the arrangements made for follow-up at the destination, and that she understood the risks.
• The anti-D given and the scheduled repeat hCG.

Respecting her autonomy does not mean dropping the plan. It means making the plan portable and legible.

This is a suboptimal rise - about 18% over 48 hours.

For a potentially viable intrauterine pregnancy at these low levels, hCG should roughly rise by at least 35–53% in 48 hours. An 18% rise is abnormal and points to either a nonviable intrauterine pregnancy or an ectopic pregnancy. It does not diagnose either one, but it removes "normal early pregnancy" from the top of the list and makes ectopic the concern that drives management.

Next steps:

• Repeat hCG and transvaginal ultrasound in 2–3 days. The goal is to localize the pregnancy or to demonstrate a fall consistent with a resolving pregnancy.
• If an adnexal mass or free fluid appears, manage as presumed ectopic: if she is hemodynamically stable, has an hCG under roughly 5,000, no fetal cardiac activity, and reliable follow-up, methotrexate is appropriate after confirming renal and hepatic function and CBC.
• Screen for methotrexate contraindications: breastfeeding, immunodeficiency, blood dyscrasias, hepatic or renal disease, and inability to return for follow-up.
• If the hCG plateaus or declines with no intrauterine pregnancy, she likely has a failed PUL and can be managed expectantly with serial hCG, or with methotrexate if the trend plateaus.
• Continue return precautions and confirm her Rh status has been addressed.

The judgment point is that a single reassuring-looking number is not the answer - the trajectory localizes the pregnancy, and while the diagnosis remains unknown, the patient stays in a monitored pathway.